Hepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer development
Open Access
- 1 September 2012
- journal article
- review article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 361 (1-2) , 1-11
Abstract
No abstract availableKeywords
This publication has 124 references indexed in Scilit:
- Cryptochromes mediate rhythmic repression of the glucocorticoid receptorNature, 2011
- Glucocorticoid therapy of antigen-induced arthritis depends on the dimerized glucocorticoid receptor in T cellsProceedings of the National Academy of Sciences, 2011
- Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in miceHepatology, 2011
- The Transcription Factors Signal Transducer and Activator of Transcription 5A (STAT5A) and STAT5B Negatively Regulate Cell Proliferation Through the Activation of Cyclin-Dependent Kinase Inhibitor 2b ( Cdkn2b ) and Cdkn1a ExpressionHepatology, 2010
- Disruption of the growth hormone—Signal transducer and activator of transcription 5—Insulinlike growth factor 1 axis severely aggravates liver fibrosis in a mouse model of cholestasis†Hepatology, 2010
- Biological effects of growth hormone on carbohydrate and lipid metabolismGrowth Hormone & IGF Research, 2010
- Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF ExpressionCell, 2010
- Liver-specific Deletion of the Growth Hormone Receptor Reveals Essential Role of Growth Hormone Signaling in Hepatic Lipid MetabolismJournal of Biological Chemistry, 2009
- Loss of STAT5 causes liver fibrosis and cancer development through increased TGF-β and STAT3 activationJournal of Experimental Medicine, 2009
- Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5BGenes & Development, 2008